WP1066 is a inhibitor of JAK2 (IC50: 2.30 µM) and STAT3 (IC50: 2.43 µM) in HEL cells, shows activity to JAK2, STAT3/5, and ERK1/2, not JAK1 and JAK3. WP1066 has been used in trials studying the treatment of Melanoma, Brain Cancer, Solid Tumors, and Central Nervous System Neoplasms.
Molecular Weight:
356.22
Purity:
98.59%
CAS Number:
[857064-38-1]
Formula:
C17H14BrN3O
Target:
Apoptosis|||STAT|||JAK
T2156
* VAT and and shipping costs not included. Errors and price changes excepted
